About Albany Molecular Research
Albany Molecular Research, Inc. is a global contract research and manufacturing company. The Company provides drug discovery, development, and manufacturing services. The Company operates through three segments: Discovery and Development Services (DDS), Active Pharmaceutical Ingredients (API) and Drug Product Manufacturing (DPM). The DDS segment includes activities, such as drug lead discovery, optimization, drug development and small-scale commercial manufacturing. API includes pilot to commercial scale manufacturing of active pharmaceutical ingredients and intermediates and high potency and controlled substance manufacturing. DPM includes pre-formulation, formulation and process development through commercial scale production of complex liquid-filled and lyophilized injectable formulations. It supplies a range of services and technologies supporting the discovery and development of pharmaceutical products, the manufacturing of API and drug product for new and generic drugs.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Biotechnology
- Sub-Industry: N/A
- Exchange: NASDAQ
- Symbol: AMRI
- Previous Close: $15.22
- 50 Day Moving Average: $18.03
- 200 Day Moving Average: $16.79
- 52-Week Range: $41,590,000.00 - $12.45
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: 11.44
- P/E Growth: 1.12
- Market Cap: $633.00M
- Outstanding Shares: 41,590,000
- Beta: 1.26
- Net Margins: -10.48%
- Return on Equity: 7.25%
- Return on Assets: 2.26%
Companies Related to Albany Molecular Research:
- Debt-to-Equity Ratio: 1.79%
- Current Ratio: 2.21%
- Quick Ratio: 1.11%
What is Albany Molecular Research's stock symbol?
Albany Molecular Research trades on the NASDAQ under the ticker symbol "AMRI."
Where is Albany Molecular Research's stock going? Where will Albany Molecular Research's stock price be in 2017?
1 brokerages have issued 1 year target prices for Albany Molecular Research's shares. Their predictions range from $17.00 to $17.00. On average, they anticipate Albany Molecular Research's stock price to reach $17.00 in the next twelve months.
When will Albany Molecular Research announce their earnings?
Albany Molecular Research is scheduled to release their next quarterly earnings announcement on Monday, May, 8th 2017.
Who owns Albany Molecular Research stock?
Albany Molecular Research's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Dimensional Fund Advisors LP (3.66%), Royce & Associates LP (3.10%), Loomis Sayles & Co. L P (1.57%), State Street Corp (1.23%), Netols Asset Management Inc. (0.97%) and Renaissance Technologies LLC (0.86%). Company insiders that own Albany Molecular Research stock include Ambra Constance M D, Ambra Thomas E Phd D, Anthony J Maddaluna, George Svokos, Kevin Oconnor, Lori M Henderson, Steven R Hagen, Stuart M Cable and William S Marth.
Who sold Albany Molecular Research stock? Who is selling Albany Molecular Research stock?
Albany Molecular Research's stock was sold by a variety of institutional investors in the last quarter, including Clough Capital Partners L P, Dimensional Fund Advisors LP, Allianz Asset Management AG, Netols Asset Management Inc., Loomis Sayles & Co. L P, Putnam Investments LLC, Bessemer Group Inc. and NN Investment Partners Holdings N.V.. Company insiders that have sold Albany Molecular Research stock in the last year include Kevin Oconnor, Lori M Henderson and Steven R Hagen.
Who bought Albany Molecular Research stock? Who is buying Albany Molecular Research stock?
Albany Molecular Research's stock was acquired by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., Royce & Associates LP, State Street Corp, Denver Investment Advisors LLC, Ranger Investment Management L.P., GSA Capital Partners LLP, Renaissance Technologies LLC and Comerica Bank. Company insiders that have bought Albany Molecular Research stock in the last two years include Anthony J Maddaluna, George Svokos and William S Marth.
How do I buy Albany Molecular Research stock?
Shares of Albany Molecular Research can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Albany Molecular Research stock cost?
One share of Albany Molecular Research stock can currently be purchased for approximately $15.22.